Long-term safety of nipple sparing mastectomy for women with genetic breast cancer risk
Official title: Long-term Oncologic Safety of Nipple Sparing Mastectomy in Women With High Penetrance Germline Pathogenic Variants in Breast Cancer Susceptibility Genes
Run by Sir Mortimer B. Davis - Jewish General Hospital · NCT06888388 · Data updated 2026-11-12
This study is testing the long-term safety of nipple-sparing mastectomy for women with a genetic risk of breast cancer to see if it’s a good option for those who want to keep their nipple area.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | Women only |
| Enrollment | 4700 (estimated) |
| Sponsor | Sir Mortimer B. Davis - Jewish General Hospital Academic / other |
| Locations | 16 sites (New Haven, Connecticut and 15 other locations) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2028 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT06888388 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 and older with confirmed GPV in BRCA1, BRCA2, PALB2, TP53, CDH1, or PTEN.
✕Probably not a fit
Patients with a history of breast or ovarian cancer prior to genetic testing or those with a variant of uncertain significance may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the long-term safety of nipple sparing mastectomy (NSM) in women with germline pathogenic variants (GPV) in high-penetrance breast cancer susceptibility genes. It aims to provide data on the oncologic safety of NSM compared to traditional mastectomy techniques, as many patients desire to preserve their nipple areola complex for improved psychosocial and sexual well-being. The study will gather information from patients considering risk-reducing mastectomy to assess outcomes and safety over time.
Why it matters
Potential benefit: If successful, this study could provide critical evidence supporting the safety of nipple sparing mastectomy, enhancing patient quality of life and body image.
How similar studies have gone: Previous studies have shown low rates of subsequent breast cancer in BRCA1/2 carriers following nipple sparing mastectomy, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Assigned female sex at birth * Age 18 years or older * Confirmed GPV in BRCA1, BRCA2, PALB2, TP53, CDH1 or PTEN identified on pre-symptomatic genetic testing Exclusion Criteria: * History of breast cancer prior to genetic testing * History of ovarian cancer prior to genetic testing * History of bilateral mastectomy performed prior to genetic testing * Presence of a variant of uncertain significance (VUS) in the absence of another GPV in BRCA1, BRCA2, PALB2, TP53, CDH1 or PTEN.
Where it's running
-
Yale University
New Haven, Connecticut, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
University of Calgary
Calgary, Alberta, Canada Recruiting -
Hamilton Health Sciences
Hamilton, Ontario, Canada Recruiting -
Jewish General Hospital
Montreal, Quebec, Canada Recruiting -
CHU de Quebec Université laval
Québec, Quebec, Canada Recruiting
Show 10 more locations
-
Cancer Institute Hospital of JFCR, Tokyo
Tokyo, Japan Recruiting -
Asan Medical Centre
Seoul, South Korea Recruiting -
Belfast Health & Social Care Trust
Belfast, United Kingdom Recruiting -
Brigham and Women's Hospital - Dana-Farber Brigham Cancer Center
Boston, Massachusetts, United States Not yet recruiting -
Memorial Sloan Kettering Cancer Center (MSKCC)
New York, New York, United States Not yet recruiting -
University of Rochester, Wilmot Cancer Institute
Rochester, New York, United States Not yet recruiting -
University of Melbourne, Peter MacCallum Cancer Center
Melbourne, Australia Not yet recruiting -
Ziekenhuis Aan de Stroom
Antwerp, Belgium Active not recruiting -
Women's College Hospital, University of Toronto
Toronto, Ontario, Canada Not yet recruiting -
Champalimaud Foundation, University of Lisbon
Lisbon, Portugal Not yet recruiting
Study contacts
- Study coordinator: Stephanie Wong, MD
- Email: sm.wong@mcgill.ca
- Phone: 5143408222
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Confocal Histolog Scanner for checking margins during lumpectomy
This project will test whether using a confocal Histolog Scanner during lumpectomy helps surgeons find cancer at the edges of removed tissue and reduce the need for repeat operations in women having breast-conserving surgery.
-
Comparing surgical techniques for improving breast skin sensitivity after reconstruction
This study is testing if using special nerve stitches during breast reconstruction can help improve skin sensitivity for women who have had surgery for breast cancer or genetic conditions.
-
Preoperative magnetic clip versus wire localization for breast-conserving surgery in France.
This project tests whether magnetic clips or traditional metal wires work better and cost less for women having breast-conserving surgery to locate a single, non-palpable breast cancer lesion.
-
Using magnetic seeds to locate breast cancer tumors
This study is testing whether a special magnetic seed can help doctors find hard-to-detect breast cancer tumors and lymph nodes better before surgery.
-
Using low doses of esketamine to improve sleep quality after breast cancer surgery
This study is testing whether low doses of esketamine can help improve sleep quality for people recovering from breast cancer surgery.
-
Assessing quality of life after breast cancer surgery
This study looks at how people with breast cancer feel and recover after oncoplastic breast surgery over five years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.